NCT00951613 A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00921739 Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies Status COMPLETED Phase PHASE1
NCT00916669 A Randomized Study to Evaluate the Effect of Two Different Doses of Enoxaparin Sodium in Combination With Standard Chemotherapy in Patients With Stage Small Cell Lung Cancer (SCLC) Status WITHDRAWN Phase PHASE2
NCT00912392 Etoposide-Carboplatin Alone or With Endostar for Extensive Disease Small Cell Lung Cancer (ED-SCLC) Status COMPLETED Phase PHASE2
NCT00883181 A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy Status COMPLETED Phase N/A
NCT00856830 Bendamustine With Irinotecan Followed by Etoposide/Carboplatin for Patients With Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00812266 Topotecan and Cisplatin Versus Etoposide and Carboplatin in 1st Line Treatment of Patients With Small Cell Lung Cancer and Extensive Disease (SCLC-ED) Status TERMINATED Phase PHASE3
NCT00791154 QUILT-2.013: First-Line Treatment for Extensive Stage Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00776295 Autologous SCT Followed by Dendritic Cell p53 Vaccination in Patients With Limited Stage Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00765973 Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT00755157 Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer Status WITHDRAWN Phase PHASE2
NCT00717938 A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00702962 Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00697476 Study of Oral Vorinostat in Combination With Topotecan in Patients With Chemosensitive Recurrent SCLC Status TERMINATED Phase PHASE1/PHASE2
NCT00695292 Irinotecan, Carboplatin, and Sunitinib in First Line Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00686985 Docetaxel - Carboplatin As Second Line Treatment in Patients with Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00617409 To Immunize Patients With Extensive Stage SCLC Combined With Chemo With or Without All Trans Retinoic Acid Status COMPLETED Phase PHASE2
NCT00613626 Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00572923 Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans Status COMPLETED Phase N/A